Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations by Line B. Nilsen et al.
BREAST
Quantitative analysis of diffusion-weighted magnetic resonance
imaging in malignant breast lesions using different
b value combinations
Line B. Nilsen & Anne Fangberget & Oliver Geier &
Therese Seierstad
Received: 15 May 2012 /Revised: 16 August 2012 /Accepted: 30 August 2012 /Published online: 31 October 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract
Objectives To explore how apparent diffusion coefficients
(ADCs) in malignant breast lesions are affected by selection
of b values in the monoexponential model and to compare
ADCs with diffusion coefficients (Ds) obtained from the
biexponential model.
Methods Twenty-four women (mean age 51.3 years) with
locally advanced breast cancer were included in this study.
Pre-treatment diffusion-weighted magnetic resonance imag-
ing was performed using a 1.5-T system with b values of 0,
50, 100, 250 and 800 s/mm2. Thirteen different b value
combinations were used to derive individual monoexponen-
tial ADC maps. All b values were used in the biexponential
model.
Results Median ADC (including all b values) and D were
1.04×10-3mm2/s (range 0.82–1.61×10-3mm2/s) and 0.84×
10-3mm2/s (range 0.17–1.56×10-3mm2/s), respectively.
There was a strong positive correlation between ADCs and
Ds. For clinically relevant b value combinations, maximum
deviation between ADCs including and excluding low b
values (<100 s/mm2) was 11.8 %.
Conclusion Selection of b values strongly affects ADCs of
malignant breast lesions. However, by excluding low b values,
ADCs approach biexponential Ds, demonstrating that micro-
perfusion influences the diffusion signal. Thus, care should be
taken when ADC calculation includes low b values.
Key Points
• Diffusion-weighted sequences are increasingly used in
breast magnetic resonance imaging
• Diffusion-weighting (b) values strongly influence appar-
ent diffusion coefficients of malignant lesions
• Exclusion of low b values reduces the apparent diffusion
coefficient
• Flow-insensitive monoexponential apparent diffusion
coefficients approach biexponential diffusion coefficients
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Introduction
The apparent diffusion coefficient (ADC), derived from
non-invasive, in vivo diffusion-weighted magnetic reso-
nance imaging (DW MRI), is increasingly being included
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as a quantitative parameter in the radiological assessment
of cancer [1, 2]. The ADC reflects the Brownian intra-
and extracellular motion of water molecules in biological
tissue and thus provides information about the tumour
microenvironment [3]. Calculation of the ADC requires
acquisition of at least two series of DW MR images with
different degrees of diffusion-weighting (b value). In-
creasing b value leads to decreasing signal intensity (SI)
on DW MRI images. The SI attenuation can be described
by the monoexponential function:
SI ¼ SI0  ebADC ð1Þ
where SI0 is the DW MR image acquired without
diffusion-weighting (b00 s/mm2). The ADC is the gra-
dient of the straight line fitted to the logarithm of this
function. Thus, areas of diffusion restriction appear
bright on DW MR images and dark on corresponding
ADC maps.
Several potential applications for the ADC in breast
cancer have been suggested and studied; including detec-
tion, characterisation, differentiation of tumours as well as
evaluation of neoadjuvant treatment response [1, 2, 4–8].
ADC has been found to correlate with cell density and
studies have reported increasing ADC during neoadjuvant
chemotherapy, reflecting reduced cellularity due to cell
damage and/or death [6–8]. Currently, the most unambigu-
ous results have been found when ADC is used to differen-
tiate between malignant and benign breast lesions [2].
Including ADC in the characterisation of tumours has been
shown to increase the diagnostic accuracy compared with
dynamic contrast-enhanced MRI alone [9–11]. However,
ADC of malignant and benign breast lesions has been
shown to overlap, both within and between different studies,
and there is no established cut-off value. Reported ADCs of
malignant and benign lesions vary from 0.68 to 1.61×10-3
mm2/s [12, 13] and from 1.35 to 1.77×10-3mm2/s [14, 15],
respectively, whereas previously reported ADCs of normal
breast tissue range from 1.51 to 2.09×10-3mm2/s [16, 17].
Different b value combinations and calculation schemes as
well as imaging-dependent factors [18] are anticipated to
contribute to the large discrepancy in published ADCs.
In addition to tissue diffusivity, the ADC incorporates the
effects of the microcirculatory perfusion of blood (flow),
especially at low b values (<100–150 s/mm2) [1]. ADCs
calculated using only low b values are thus flow-sensitive.
To reduce perfusion effects and obtain flow-insensitive
ADC or ADCslow, it has been recommended to omit low b
values from the monoexponential model [1]. It has also been
suggested that using a biexponential model, accounting for a
vascular compartment in addition to the extravascular extra-
cellular and intracellular compartment, may better reflect
“true” diffusion without microperfusion contamination [3].
In the biexponential model, the DW MRI SI attenuation is
described by the following function:
SI ¼ SI0 1 fp
   ebD þ fp  ebD
  ð2Þ
where D* is the pseudo-diffusion coefficient of the vascular
compartment occupying a volume fraction, fp, and D is the
pure water molecular tissue diffusion coefficient of com-
partment (1-fp) [3].
Traditionally, breast ADCs have been calculated using
the monoexponential model. But, there is no consensus on
an optimal b value combination and generally b00 s/mm2 is
included. The purpose of this study was to examine how the
choice of b values included in the monoexponential model
affects calculated ADCs and also to compare these with Ds
derived from the biexponential model.
Materials and methods
Patients
Twenty-four women diagnosed with locally advanced breast
cancer were included in this prospective study. The mean age
at time of inclusion was 51.3 years (range 37–72 years).
Eighteen lesions were categorised as invasive ductal carcino-
mas (grade 2, n07; grade 3, n08; not determined, n03) and 6
lesions as invasive lobular carcinomas (grade 2, n04 and
grade 3: n02). The mean initial clinical tumour size (longest
tumour diameter) of the breast lesions was 6.7 cm (range 5–
11 cm). Written consent was obtained from all women and the
study was approved by the regional ethics committee and the
protocol review committee of our institution.
MR examination
The MR examination was performed as part of the radio-
logical pre-treatment assessment of the extent of the disease.
Patients underwent imaging in the prone position using a
dedicated phased-array bilateral breast coil (CP Breast array
coil, Siemens) on a 1.5-T MR system (ESPREE, Siemens,
Erlangen, Germany). To reduce motion artefacts during
imaging, cotton pads were put inside the breast coils and
care was taken to avoid compression of the breasts.
Diffusion-weighted MRI was carried out using a single-
shot spin-echo echo-planar imaging sequence with fat-
saturated short T1 inversion recovery and b values of 0,
50, 100, 250 and 800 s/mm2 in three orthogonal directions,
and the total imaging time was 6:52 min. The following DW
MRI imaging parameters were used: repetition time (TR)0
10,300 ms; echo time (TE)0126 ms; inversion time (TI)0
190 ms; slice thickness04 mm; slice gap02 mm; number of
slices026; number of excitations (NEX)03; field of view0
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360 mm×195 mm; image matrix0192×104; echo spacing0
0.94 ms; bandwidth01,240 Hz/pixel; phase encoding from
anterior to posterior. The MR examination also included
sagittal turbo spin-echo T1-weighted MRI, axial turbo
spin-echo T2-weighted MRI and T1-weighted 3D dynamic
contrast-enhanced (DCE) MRI with gadopentetate dimeglu-
mine (Magnevist, Schering, Berlin, Germany) as contrast
agent (0.1 mmol/kg body weight). The DCE MRI included
acquisition of one pre-enhanced and four enhanced sequen-
ces with a time resolution of 85 s. DW MRI was acquired
before contrast agent injection.
Diffusion analysis
A region of interest (ROI) was drawn manually within a solid
part of each breast lesion on an ADC map calculated using all
b values in the commercially available nICE software package
(Nordic NeuroLab, Bergen, Norway). The drawing of the ROI
was guided by the native b800 image and the DCE MRI
subtraction image (second postcontrast DCE MRI image –
precontrast DCE MRI image) from the same anatomical lo-
cation as the ADC map. The placement of the ROI was
verified by an experienced breast radiologist. Further calcu-
lations of ADCs, Ds, D*s and fps were performed for all ROIs
on a voxel-by-voxel basis using in-house written IDL routines
(Interactive Data Language [IDL] version 6.3; Research Sys-
tem, Boulder, CO, USA). In each voxel of the ROI, the DW
MRI SI as a function of the b value was fitted to the mono- and
biexponential models, using Levenberg–Marquardt least
squares minimisation implemented in the commercially avail-
able IDL procedure MPFIT (Markwardt CB, presented at the
2008 conference Astronomical Data Analysis Software and
SystemsXVIII). The goodness of fit betweenmeasured SI and
fitted curves was evaluated by the Pearson’s correlation coef-
ficient squared (r2) and the summed squared residuals of the
fit (χ2).Voxels where the curve fitting resulted in low r2 or
high χ2 were excluded from further analysis.
The 13 different combinations of b values, B0–B12, used
in the monoexponential model are shown in Table 1. B0–B5
are b value combinations with currently clinical relevance.
All b values (B0biexp) were used in the biexponential model.
Statistical analysis was performed on median ADCBXs, Ds,
D*s and fps of individual breast lesion ROIs.
Statistical analysis
All statistical analysis was performed using SPSS version
18.0 (SPSS, Chicago, IL, USA). Ds and ADCs calculated
using the different b value combinations were compared
using the non-parametric Wilcoxon signed-rank test. The
non-parametric Spearman’s ρ correlation was used to eval-
uate correlations between Ds and different ADCs. The sig-
nificance level was set at 5 %.
Results
Twenty-four individual ROIs were drawn and the mean
size was 99.2±35.8 mm2 (range, 42.2–168.8 mm2). All
ROI voxels could be fitted to the monoexponential mod-
el, whereas on average 79±15 % (range, 37–100 %) of
all voxels were satisfactorily fitted to the biexponential
model. The results of monoexponential and biexponential
fitting with b value combinations B0–B11 are shown in
Table 2. Median ADC for the b value combinations
using only low b values (B7–B11) were significantly
higher than the corresponding ADCs calculated using
currently clinically relevant b value combinations (B0-
B5) (P<0.001). Figure 1 shows DW MR images for
different b values (a–e) for a woman with a solid
contrast-enhancing malignant lesion in the right breast
(f). Logarithmic SI as a function of b value for a single
voxel (red arrow in images a–e) is shown in g. Fitted
curves using the monoexponential model and all b values
(B0, dotted black line), only low b values (B7, dashed
red line) and only high values (B4, dashed blue line) are
displayed together with the fitted curve obtained using
the biexponential model with all b values (B0biexp, solid
green line). The curvature of the SI attenuation is indic-
ative of a non-monoexponential behaviour with increas-
ing b values that is well-characterised by a biexponential
function, with an initial drop for b values less than
100 s/mm2.
Figure 2 shows a box-plot illustrating the distribution of
biexponential median Ds (white box) and median ADCs
(grey boxes) for different b value combinations. Comparison
of monoexponential median ADCB0-B5 and biexponential D
is shown in Table 3. Median ADC was reduced by at most
10.6 % (P<0.001) when b values <100 mm2/s were
Table 1 The different b
value combinations
(BXsa) explored in the
study
aX ranges from 0 to 12
for b value combina-
tions used in the mono-
exponential model, and
it is 0biexp for the b value
combination used in the
biexponential model.
BX b values [s/mm2]
B0 0, 50, 100, 250, 800
B1 0, 800
B2 50, 800
B3 50, 100, 250, 800









B0biexp 0, 50, 100, 250, 800
Eur Radiol (2013) 23:1027–1033 1029
excluded from the calculations (Table 3). D was significant-
ly lower than all ADCsB0–B12 (P<0.001). Positive correla-
tions were found between Ds and ADCsB0-B6,B9 (P<0.01).
The largest inter-patient variations were found for b value
combinations including b<100 s/mm2 (Fig. 2).
The median biexponential D* was 11.9 (range 4.3–72.1)
and median fp was 16 % (range 5–55 %). There was no
correlation between D* and ADCs calculated using the three
lowest b values ADCB7–B8.
Discussion
This study shows that there is significant variability in
monoexponentially calculated breast tumour ADCs when
different b value combinations are used. However, for clin-
ically used b value combinations (B0–B5), the maximum
deviation is only 11.8 % (Table 3). The variability in calcu-
lated ADCs is reduced when low b values are omitted.
Although ADCs are overestimated compared with biexpo-
nentially calculated Ds, there is a strong correlation between
these two parameters.
Breast tumour ADCs for clinically used b value combi-
nations in our study (mean 1.07–1.16×10-3mm2/s, median
0.97–1.09×10-3mm2/s) are within the range of previously
reported values (0.68–1.61×10-3mm2/s) [12, 13]. Conse-
quently, for single-institution monitoring of individual treat-
ment response using ADC, the b value combination may be
of limited value, especially if low b values are excluded.
But, clinical use of ADC cut-off values for tissue differen-
tiation requires standardisation of acquisition protocol.
It has been suggested that the choice of b value
combination have limited impact on the differentiation
between malignant and benign breast lesions as studies
have shown equal diagnostic performance of monoexpo-
nential flow-insensitive ADCs and ADCs calculated in-
cluding low b values [12, 19, 20]. However, Ds from the
biexponential model have been shown to provide better
differentiation than ADCs [21]. Furthermore, including b
values >1,000 s/mm2 in the ADC calculation might im-
prove the differential diagnostic accuracy [11] as this
reduces the contamination from microperfusion and
ADC approaches the biexponentially derived D. But, if
the b value is too high for the available signal-to-noise
ratio the ADC will be underestimated. In our study, flow-
insensitive ADCs of malignant breast lesions were corre-
lated with biexponentially calculated Ds (P<0.01), but
overestimated by about 23 % (Table 3), which is in
accordance with previously published results [21]. This
may reflect the high vascularity and high cellularity of
these lesions; further radiological–histopathological corre-
lation analyses are needed. The microperfusion effect in
normal breast tissue has been shown to be limited, yield-
ing similar ADCs and Ds [21, 22], and thereby support-
ing the validity of the biexponential model.
A limitation to our study is the small and homoge-
neous study population, consisting of patients with large
malignant tumours (mean 6.7 cm). Although our study
included two different tumours types, i.e. invasive lob-
ular (25 %) and ductal (75 %) carcinomas, there were
no apparent differences between these types with respect
to growth pattern, ADCs or contrast-enhancement char-
acteristics on DCE MRI.
The large inter-patient variations in monoexponential
ADCs calculated from only low b values found in this study
may be attributed to microperfusion heterogeneity, a feature
being of great importance in the exploration of anti-
angiogenic treatment [23]. It has been hypothesised that
Table 2 Comparison of mono-
exponentially and biexponen-
tially calculated diffusion
coefficients: results of calcula-
tion with B0–B11 and B0biexp
ADC monoexponential apparent
diffusion coefficient, D diffusion
coefficient derived from the
biexponential model, B0-B11
and B0biexp b value combinations
defined in Table 1, SD standard
deviation, CI median confidence












ADCB0 1.12±0.24 1.04 0.82–1.61 0.81–1.31 >0.987
ADCB1 1.16±0.23 1.09 0.84–1.65 1.0
ADCB2 1.10±0.24 1.01 0.78–1.59 1.0
ADCB3 1.09±0.24 0.99 0.77–1.58 0.78–1.29 >0.994
ADCB4 1.07±0.25 0.97 0.74–1.60 0.53–1.71 >0.997
ADCB5 1.08±0.24 0.98 0.76–1.61 1.0
ADCB6 1.03±0.25 0.96 0.69–1.64 1.0
ADCB7 2.32±0.65 2.24 1.40–3.88 1.0
ADCB8 1.89±0.41 1.86 1.11–2.91 1.0
ADCB9 1.51±0.30 1.41 1.04–2.18 1.0
ADCB10 1.55±0.41 1.56 0.77–2.26 1.0
ADCB11 1.32±0.26 1.27 0.98–2.00 1.0
D B0biexp 0.90±0.30 0.84 0.17–1.56 0.54–1.22 >0.999
1030 Eur Radiol (2013) 23:1027–1033
Fig. 1 Axial diffusion-weighted images with b values 0 (a), 50 (b),
100 (c), 250 (d) and 800 s/mm2 (e) and corresponding axial contrast-
enhanced T1-weighted subtraction image (DCE MRI) (f) of the right
breast of a patient with invasive ductal carcinoma (grade 2).
Attenuation of the DW MRI signal from a single voxel within the
breast lesion (red arrow in a–e) is plotted together with the monoex-
ponential and biexponential model fits with all b values (B0/B0biexp),
b0100, 250 and 800 s/mm2 (B4) and b00 and 50 s/mm2 (B7) (g)
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D* and fp may reflect microvessel perfusion. Weak correla-
tions have been reported between fp and initial enhancement
on DCE MRI [21]. But in accordance with our results, the
SDs of fp and D* were large [21], and the clinical use of
these parameters is questionable. The biological relevance
of the biexponential model is not established as there is no
clear evidence that the modelled compartments correspond
to intravascular and extravascular flow and diffusion. Thus,
other mathematical models may be more suitable for de-
scribing the DW MRI SI attenuation [24].
In our study the biexponential model provided poorer
fitting than did the monoexponential model. This is proba-
bly a result of the limited number of low b values included.
Since at least four DW MRI series with different b values
are required in the biexponential model, the accuracy of the
derived parameters is anticipated to increase with increasing
number of b values. Despite the limited number of b values
used in our study, calculated Ds, D*s and fps are comparable
to those obtained in a study using several more b values
[21]. The selected number of b values causes a trade-off
between increased precision in the estimated diffusion
parameters and acquisition time.
In this study, median and mean diffusion values from
single ROIs, placed within a solid part of the lesions,
were used. This was done to minimise the influence of
partial volume effects and limited spatial resolution. The
differences between median and mean ADCs were found
to be to the same order as the differences between ADCs
Fig. 2 Box-plot of median individual breast lesion diffusion coeffi-
cients (first box in white) and apparent diffusion coefficients (grey
boxes) calculated using respectively the biexponential model with all
b values (B0biexp: b00, 50, 100, 250 and 800 s/mm
2) and the mono-
exponential model with the following b value combinations: B0 (all b
values), B1: b00 and 800 s/mm2, B2: b050 and 800 s/mm2, B3: b050,
100, 250 and 800 s/mm2, B4: b0100, 250 and 800 s/mm2, B5: b0100
and 800 s/mm2, B6: b0250 and 800 s/mm2, B7: b00 and 50 s/mm2,
B8: b00 and 100 s/mm2, B9: b00 and 250 s/mm2, B10: b050 and
100 s/mm2, B11: b050 and 250 s/mm2 and B12: b0100 and 250 s/
mm2. The horizontal solid and dotted lines within each box represents
the median and the mean, respectively. The black circles represent
outliers and the top and bottom of the boxes show the 95th and the
5th percentiles
Table 3 Comparison of monoexponentially and biexponentially calculated diffusion coefficients: deviation [%] and Spearman’s ρ correlation of
median values for B0-B5 and B0biexp
ADCB0 ADCB1 ADCB2 ADCB3 ADCB4 ADCB5 DB0biexp
ADCB0 0 -4.7*** 2.4*** 5.1*** 6.6*** 5.4*** 23.2***
ADCB1 4.9*** 0 7.4*** 10.2*** 11.8** 10.6*** 29.2***
ADCB2 -2.3*** -6.9*** 0 2.6* 4.1* 3.0* 20.3***
ADCB3 -4.8*** -9.3*** -2.5* 0 1.4* 0.3 17.2***
ADCB4 -6.2*** -10.6*** -3.9** -1.4** 0 -1.1* 15.6***
ADCB5 -5.1*** -9.6*** -2.9* -0.3 1.1* 0 16.8***
DB0biexp -18.8*** -22.6*** -16.9*** -14.7*** -13.5** -14.4*** 0
Correlation: DB0biexp and ADCB0-B5 0.57** 0.56** 0.56** 0.54** 0.58** 0.54** 1
ADC monoexponential apparent diffusion coefficient, D diffusion coefficient derived from the biexponential model, B0-B5 and B0biexp b value
combinations defined in Table 1, deviation
* P<0.05, deviation ** P<0.01 and deviation *** P<0.001 (Wilcoxon signed rank test), Spearman’s ρ correlation test between median DB0biexp
and ADCB0-B5, ρ** P<0.01
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calculated using the different b value combinations (B0–B5).
Histogram analysis including the entire lesion would perhaps
depict lesion heterogeneity better. However, mean values
obtained from single ROIs have been used in previously
published clinical DW MRI studies of breast cancer [2].
In conclusion, this study demonstrates that using differ-
ent b value combinations strongly influences the calculated
ADCs. Removing low b values reduces the perfusion con-
tamination of the diffusion signal and ADCs approach the
biexponentially calculated Ds. Thus, care should be taken
when ADC calculation includes low b values. Future studies
involving a larger number of patients should be undertaken
in order to further validate these findings.
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